EXTON, Pa. , Dec. 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Janet Haugen as its newest member. With the addition of Ms. Haugen, West's Board has 12 directors.... Read More

EXTON, Pa. , Oct. 29, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following conferences: UBS Global Healthcare Conference in Rancho Pablos Verdes, California , on November 12, 2024 at 3:30 PM PST Jefferies Healthcare Conference in London, UK on Tuesday, November 19, 2024 at 1:00 PM... Read More

Conference Call Scheduled for 9 a.m. EDT Today EXTON, Pa. , Oct. 24, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2024 and declared a fourth-quarter 2024 dividend. Third-Quarter 2024 Summary (comparisons to prior-year period) Net sales of $746.9 million declined 0.1%; organic net sales decline was 0.5%. Reported-diluted EPS of $1.85 , compared... Read More

EXTON, Pa. , Oct. 22, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced participation in the 2024 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Phoenix , AZ to showcase its leadership and expertise on industry challenges and trends in packaging and containment. "With the rise of biologic... Read More

EXTON, Pa. , Oct. 10, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 24, 2024 , and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time . The live webcast... Read More

EXTON, Pa. , Oct. 9, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that it has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with Fox Chase Cancer Center, a part of the... Read More

EXTON, Pa. , Oct. 7 , 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPHI Worldwide in Milan, Italy to showcase leadership and expertise on industry challenges and trends in packaging and containment. This year, West will highlight its industry expertise through a technical-focused... Read More

EXTON, Pa. , Sept. 5, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Global Healthcare Conference in London, UK on Wednesday, September 18, 2024 , at 9:55 AM BST . A live audio webcast of the event will be available in the "Investors" section of the Company's website at... Read More

Conference Call Scheduled for 9 a.m. EDT Today EXTON, Pa. , July 25, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2024 and updated full-year 2024 financial guidance. Second-Quarter 2024 Summary (comparisons to prior-year period) Net sales of $702.1 million declined 6.9%; organic net sales declined 5.9%. Reported-diluted EPS of $1.51 ,... Read More

EXTON, Pa. , July 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter financial results before the market opens on Thursday, July 25, 2024 , and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time . The live audio-only... Read More

CZ's Nested Vials are designed to meet the exterior dimensions of glass standard ISO 8362-1 and offer broad compatibility with various aseptic fill-finish equipment available in the market. EXTON, Pa. , May 29, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for... Read More

EXTON, Pa. , May 28, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the William Blair 44 th Annual Growth Stock Conference in Chicago, IL on Tuesday, June 4, 2024 at 8:00 AM CT . A live audio webcast of the event will be available in the "Investors" section of the Company's website at... Read More

EXTON, Pa. , April 30, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Securities Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2024 , at 11:20 AM PT . A live audio webcast of the event will be available in the "Investors" section of the Company's website at... Read More

Conference Call Scheduled for 9 a.m. EDT Today EXTON, Pa. , April 25, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2024 and updated full-year 2024 financial guidance. First-Quarter 2024 Summary (comparisons to prior-year period) Net sales of $695.4 million declined 3.0%; organic net sales also declined by 3.0%. Reported-diluted EPS of $1.55... Read More

EXTON, Pa. , April 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter financial results before the market opens on Thursday, April 25, 2024 , and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time . The live audio-only... Read More

EXTON, Pa. , Feb. 28, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 26th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 12, 2024 , at 1:05 PM ET . It will also present at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024... Read More

EXTON, Pa. , Feb. 20, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2024 dividend of $0.20 per share. The dividend will be paid on May 1, 2024 , to shareholders of record as of April 24, 2024 . About West West Pharmaceutical Services, Inc. is a... Read More

Conference Call Scheduled for 9 a.m. EST Today EXTON, Pa. , Feb. 15, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2023 and introduced full-year 2024 financial guidance. Fourth-Quarter and Full-Year 2023 Summary (comparisons to prior-year period) Fourth-quarter 2023 net sales of $732.0 million grew 3.3%; organic net sales growth... Read More

This award recognizes West's global impact and long-standing commitment to diversity, equity and inclusion. EXTON, Pa. , Feb. 7, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) , a global leader in innovative solutions for injectable drug administration, announced today that it is recognized as one of... Read More

EXTON, Pa. , Feb. 1, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2023 financial results before the market opens on Thursday, February 15, 2024 , and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.... Read More

EXTON, Pa. , Dec. 6, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2024 dividend of $0.20 per share. The dividend will be paid on February 7, 2024 , to shareholders of record as of January 31, 2024 . About West West Pharmaceutical Services, Inc.... Read More

West expands administration systems portfolio with new smaller size needle-free admixture device for immediate use IV drug transfer designed to maximize the benefits of point-of-care nursing. EXTON, Pa. , Dec. 4, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for... Read More

EXTON, Pa. , Nov. 1, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at Jefferies Healthcare Conference in London, UK on Tuesday, November 14, 2023 at 10:00 AM GBT. It will also hold a fireside chat at the Stephens Annual Investment Conference in Nashville, TN on Thursday, November 16, 2023 at... Read More

Conference Call Scheduled for 9 a.m. EDT Today EXTON, Pa. , Oct. 26, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2023, updated full-year 2023 financial guidance and declared a fourth-quarter 2023 dividend. Third-Quarter 2023 Summary (comparisons to prior-year period) Net sales of $747.4 million grew 8.8%; organic net sales growth was 5.7%.... Read More

EXTON, Pa. , Oct. 23, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPHI Worldwide in Barcelona, Spain to showcase its leadership and expertise on industry challenges and trends in packaging and containment. "West is applying its 100 years of innovation to address the changing containment... Read More

Expert presentations and posters offer thought leadership in drug delivery innovation, patient adherence and pharmaceutical manufacturing EXTON, Pa. , Oct. 16, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced participation in the 2023 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in... Read More

EXTON, Pa. , Oct. 12, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc . (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2023 financial results before the market opens on Thursday, October 26, 2023 , and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time . The live... Read More

EXTON, Pa. , Sept. 7, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at Bank of America Global Healthcare Conference in London, UK on Thursday, September 14, 2023 at 10:50 AM BST . A live audio webcast will be available in the "Investors" section of the Company's website at www.westpharma.com... Read More

EXTON, Pa. , Aug. 2, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the UBS MedTech, Tools and Genomics Summit in Dana Point, CA on Wednesday, August 16, 2023 at 3:00 – 3:45 PM PDT . A live audio webcast will be available in the "Investors" section of the Company's website at... Read More

Conference Call Scheduled for 9 a.m. EDT Today EXTON, Pa. , July 27, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2023 and updated full-year 2023 financial guidance. Second-Quarter 2023 Summary (comparisons to prior-year period) Net sales of $753.8 million declined 2.3%; organic net sales declined 2.5%. Reported-diluted EPS of $2.06 ,... Read More

EXTON, Pa. , July 13, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2023 financial results before the market opens on Thursday, July 27, 2023 , and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time . The live... Read More

EXTON, Pa. , May 24, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the William Blair 43rd Annual Growth Stock Conference in Chicago, IL on Tuesday, June 6, 2023 at 1:20pm CT . It will also present at the Jefferies Healthcare Conference in New York, NY on Wednesday, June 7, 2023 at 8:00 am... Read More

EXTON, Pa. , May 4, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Securities 2023 Health Care Conference in Las Vegas, NV , on Thursday, May 11, 2023 , at 8:00 am PDT . A live audio webcast will be available in the "Investors" section of the Company's website at... Read More

EXTON, Pa. , May 2, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that its West Ready Pack™ containment solution with Corning® Valor® RTU Vials utilizing Stevanato Group's EZ-fill® technology recently won... Read More

Conference Call Scheduled for 9 a.m. EDT Today EXTON, Pa. , April 27, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2023 and updated full-year 2023 financial guidance. First-Quarter 2023 Summary (comparisons to prior-year period) Net sales of $716.6 million declined 0.5%; organic sales growth was 2.3%. Reported-diluted EPS of $1.85 declined by... Read More

EXTON, Pa. , April 13, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2023 financial results before the market opens on Thursday, April 27, 2023 , and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time . The live... Read More

EXTON, Pa. , March 3, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announces that the Company's Board of Directors has approved a second-quarter 2023 dividend of $0.19 per share. The dividend will be paid on May 3, 2023 , to shareholders of record as of April 26, 2023 . About West West Pharmaceutical Services, Inc. is a... Read More

EXTON, Pa. , Jan. 5, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the 41 st Annual J.P. Morgan Healthcare Conference in San Francisco, CA , on Thursday, January 12, 2023 , at 9:00 am PST . A live audio webcast will be available in the "Investors" section of the Company's website at... Read More

EXTON, Pa. , Dec. 13, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc . (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announces that the Company's Board of Directors has approved a first-quarter 2023 dividend of $0.19 per share. The dividend will be paid on February 1, 2023 , to shareholders of record as of January 25, 2023 . The Company also announces that it will... Read More